Zobrazeno 1 - 10
of 319
pro vyhledávání: '"Sæbøe-Larssen S"'
Autor:
Sioud M; Department of Cancer Immunology, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379 Oslo, Norway., Juzeniene A; Department of Radiation Biology, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379 Oslo, Norway., Sæbøe-Larssen S; Department of cellular Therapy, Oslo University Hospital, Radiumhospitalet, Ullernchausseen 70, 0379 Oslo, Norway.
Publikováno v:
Vaccines [Vaccines (Basel)] 2024 Jun 05; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 05.
Autor:
Maggadottir SM; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway; Landspitali University Hospital, Reykjavik, Iceland., Dueland S; Department of Oncology, Oslo University Hospital, Oslo, Norway., Mensali N; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Hamre H; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Andresen PA; Department of Pathology, Oslo University Hospital, Oslo, Norway., Myhre MR; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Juul HV; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Bigalke I; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Lundby M; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Hønnåshagen TK; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Sæbøe-Larssen S; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Josefsen D; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Hagtvedt T; Department of Radiology, Oslo University Hospital, Oslo, Norway., Wälchli S; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Kvalheim G; Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway., Inderberg EM; Translational Research Unit, Section for Cellular Therapy, Department of Oncology, Oslo University Hospital, Oslo, Norway. Electronic address: elsin@rr-research.no.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2024 Jun 05; Vol. 32 (6), pp. 2021-2029. Date of Electronic Publication: 2024 Apr 06.
Autor:
Tryggestad AMA; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Axcrona K; Department of Urology, Oslo University Hospital HF, Oslo, Norway.; Department of Urology, Akershus University Hospital HF, Oslo, Norway., Axcrona U; Department of Pathology, Oslo University Hospital HF, Oslo, Norway., Bigalke I; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.; BioNTech IMFS GmbH, Idar-Oberstein, Germany., Brennhovd B; Department of Urology, Oslo University Hospital HF, Oslo, Norway., Inderberg EM; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Hønnåshagen TK; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Skoge LJ; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Solum G; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Saebøe-Larssen S; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Josefsen D; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Olaussen RW; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Aamdal S; Department for Clinical Research, Oslo University Hospital HF, Oslo, Norway., Skotheim RI; Department of Molecular Oncology, Oslo University Hospital HF, Oslo, Norway., Myklebust TÅ; Department of Registration, Cancer Registry Norway, Oslo, Norway.; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway., Schendel DJ; Medigene Immunotherapies GmbH, Munich, Germany., Lilleby W; Department of Oncology, Oslo University Hospital HF, Oslo, Norway., Dueland S; Department for Clinical Research, Oslo University Hospital HF, Oslo, Norway., Kvalheim G; Department of Oncology, Oslo University Hospital HF, Oslo, Norway.
Publikováno v:
The Prostate [Prostate] 2022 Feb; Vol. 82 (2), pp. 245-253. Date of Electronic Publication: 2021 Nov 11.
Publikováno v:
In Cytotherapy 2007 9(6):587-592
Autor:
Maggadóttir SM; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Kvalheim G; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Wernhoff P; Department of Medical Genetics, Institute of Clinical Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Sæbøe-Larssen S; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Revheim ME; Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway., Josefsen D; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Wälchli S; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway., Helland Å; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Inderberg EM; Translational Research Unit, Department of Oncology, Section for Cellular Therapy, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Frontiers in oncology [Front Oncol] 2022 Nov 10; Vol. 12, pp. 1031232. Date of Electronic Publication: 2022 Nov 10 (Print Publication: 2022).
Autor:
Boussios, Stergios1,2,3,4,5 (AUTHOR) stergiosboussios@gmail.com, Sheriff, Matin6 (AUTHOR) matin.sheriff@nhs.net, Ovsepian, Saak V.7,8 (AUTHOR) s.v.ovsepian@greenwich.ac.uk
Publikováno v:
International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p13090. 20p.
Autor:
Meléndez-Vázquez, Natalie M.1 (AUTHOR) natalie.melendez2@upr.edu, Gomez-Manzano, Candelaria2 (AUTHOR) cmanzano@mdanderson.org, Godoy-Vitorino, Filipa1 (AUTHOR) filipa.godoy@upr.edu
Publikováno v:
Viruses (1999-4915). Nov2024, Vol. 16 Issue 11, p1775. 23p.
Autor:
Karimi-Sani, Iman1 (AUTHOR), Molavi, Zahra2 (AUTHOR), Naderi, Samaneh1 (AUTHOR), Mirmajidi, Seyedeh-Habibeh1 (AUTHOR), Zare, Iman3 (AUTHOR), Naeimzadeh, Yasaman4 (AUTHOR), Mansouri, Atena5 (AUTHOR), Tajbakhsh, Amir6 (AUTHOR), Savardashtaki, Amir1,7 (AUTHOR) dashtaki63@gmail.com, Sahebkar, Amirhossein8,9,10 (AUTHOR) amir_saheb2000@yahoo.com
Publikováno v:
Journal of Nanobiotechnology. 10/4/2024, Vol. 22 Issue 1, p1-31. 31p.
Autor:
Sæbøe-Larssen S; Department of Cellular Therapy, Institute for Cancer Research, Oslo University Hospital-Radium, Ullernchausseen, Norway., Sioud M; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Ullernchausseen, Norway. mouldy.sioud@rr-research.no.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2020; Vol. 2115, pp. 249-258.
Autor:
Brugiapaglia, Silvia1 (AUTHOR) silvia.brugiapaglia@unito.it, Spagnolo, Ferdinando2 (AUTHOR) ferdinando.spagno57@edu.unito.it, Intonti, Simona1 (AUTHOR) simona.intonti@unito.it, Novelli, Francesco1 (AUTHOR) franco.novelli@unito.it, Curcio, Claudia1 (AUTHOR) claudia.curcio@unito.it
Publikováno v:
Cells (2073-4409). Sep2024, Vol. 13 Issue 18, p1558. 26p.